Saturday 27 November 2021

Dr Ben O. El Idrissi

Aimedis to launch first medical and scientific NFT at Gitex

DUBAI, October 5, 2021

UAE’s Aimedis will be launching the first B2B medical and scientific NFT (Non-Fungible Token) marketplace during its participation at Gitex 2021 and Future Blockchain Summit, (booth H7-20 ) between October 17 and 20. 
Launched in 2020 as a result of the need for affordable and effective healthcare, the Aimedis ecosystem consists of the Aimedis patient centered platform, the professional platform, AIMSocial + user content (video and more), Aimedis Labs & Pharmacy, Medical Tourism  applications, Aimedis records, video chat, prescriptions, second opinions, appointments and Aimedis Virtual Hospital incl. Virtual Rehab, all available on web and mobile in multiple languages. 
It also supports the world’s first medical and scientific NFT marketplace. 
Dr Ben O. El Idrissi, Co-Founder and COO of Aimedis said: “We believe every human being deserves access to a proper, safe and up-to date medical treatment wherever they are. To make this a reality, we integrated the needs of patients and professionals to create a platform that can store, transfer and validate all kinds of medical data, connect to medical devices and even provide remote supervisions to medical professionals, institutions and other patients.” 
He adds: “We are proud to be the first decentralised and incentivised healthcare platform to launch the world’s first medical and scientific B2B NFT market place, Aimedis DataXChange, that will include a combination of DeFi, governance, social, payment and utility token. This will finally mainstream and standardise the process of monetising medical and scientific data, expanding this multi-trillion-dollar market.” 
AI companies, space agencies, car manufacturers, medical hardware sellers, IoT providers, and other healthcare providers will be able to participate and contribute to this unique new B2B NFT marketplace. 
Until today medical and scientific data is hard to monetise due to non-coordinated and non-standardised data collection processes with often low-quality data evaluation processes. 
Simple issues like handwritten data acquisition errors occur frequently while data is entered and copied. This can lead to manipulated or lost data  especially due to a missing data transfer chain.
Dr Michael J Kaldasch, Co-Founder and CEO of Aimedis explained: “We moved our global headquarters to the UAE, because we believe it presents an attractive and well-regulated environment at an accessible geographic location. It is the perfect fit for the aim of our platform which allows travellers and expat communities to hold their medical data and access the best medical services possible wherever they are.” 
The company is currently expanding its team in the UAE with the hiring of data scientists, and is working to build partnerships and onboard UAE hospitals onto the platform. 
Aimedis’ participation at Gitex will coincide with the launch of its public sale. Their IDO powered by Binance Smartchain will be followed by a public sale on Pankcakeswap. Aimedis is offering 60,000,000 AIMX tokens in both its private and public sale out of a total of 600,000,000 AIMX tokens. The price per AIMX token is 0.05 USD during IDO & Pancakeswap at launch.-- TradeArabia News Service


More Health & Environment Stories

calendarCalendar of Events